| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/30/2003 | US20030202689 Ray-based image analysis for biological specimens |
| 10/30/2003 | US20030202170 Method and apparatus for direct spectrophotometric measurements in unaltered whole blood |
| 10/30/2003 | US20030201901 Measurement, calibration of gaseous effluents |
| 10/30/2003 | US20030201388 Method for measuring the concentration of nitrogen in argon by means of ion mobility spectrometry |
| 10/30/2003 | US20030201230 Using a cross-flow filter; chromatography |
| 10/30/2003 | US20030201209 Detection system for sorting apparatus |
| 10/30/2003 | US20030201208 Dynamic superparamagnetic markers |
| 10/30/2003 | US20030201194 Quantitative analysis; redox systems; monitoring glucose concentration |
| 10/30/2003 | US20030201192 Ion selectivity electrodes; medical diagnosis |
| 10/30/2003 | US20030201180 Capillary array and electrophoresis apparatus, and methods |
| 10/30/2003 | US20030201177 Hemoglobin sensor |
| 10/30/2003 | US20030201172 NOx-decomposing electrode and NOx concentration-measuring apparatus |
| 10/30/2003 | US20030201171 NOx-decomposing electrode and NOx concentration-measuring apparatus |
| 10/30/2003 | US20030201124 Double sleeve soil tester |
| 10/30/2003 | US20030200932 Ultrasound quality inspection of avian eggs |
| 10/30/2003 | US20030200810 Method and apparatus for evaluating damage of metal material |
| 10/30/2003 | US20030200791 Apparatus for determining the moisture content of a subfloor |
| 10/30/2003 | US20030200786 Monitoring impurities concentration of dielectrics; signal detecting gases effluents |
| 10/30/2003 | US20030200668 Hole center detecting apparatus, straightness measuring apparatus, and residual torsion measuring apparatus |
| 10/30/2003 | US20030200644 Electrochemical analyzing; multilayer laminated structure |
| 10/30/2003 | CA2785889A1 Peptide inhibitors of protein kinase c |
| 10/30/2003 | CA2642652A1 Blood component processing system, apparatus and method |
| 10/30/2003 | CA2492655A1 Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases |
| 10/30/2003 | CA2484397A1 Methods for measuring protein kinase and phosphatase activity |
| 10/30/2003 | CA2484102A1 Multi-element screening of trace elements |
| 10/30/2003 | CA2484097A1 Method and device for measurement of hematocrit |
| 10/30/2003 | CA2484078A1 Quantitation of biological molecules |
| 10/30/2003 | CA2483343A1 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions |
| 10/30/2003 | CA2483327A1 Oligonucleotides from coding sequences for the surface component of ptlvenvelope proteins and uses thereof |
| 10/30/2003 | CA2483227A1 Antiviral inhibition of capsid proteins |
| 10/30/2003 | CA2483144A1 Translocation dependent complementation for drug screening |
| 10/30/2003 | CA2482919A1 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1) |
| 10/30/2003 | CA2482907A1 Tissue specific genes and gene clusters |
| 10/30/2003 | CA2482897A1 Two green fluorescent protein fragments and their use in a method for detecting protein - protein interactions |
| 10/30/2003 | CA2482856A1 Plasma protein-binding ligands |
| 10/30/2003 | CA2482764A1 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 10/30/2003 | CA2482611A1 Functionalized nanoparticles and methods of use |
| 10/30/2003 | CA2482589A1 Compositions and method of treating alzheimer's disease |
| 10/30/2003 | CA2482529A1 Method for detecting ligands and targets in a mixture |
| 10/30/2003 | CA2482485A1 Matrix analysis of gene expression in cells (magec) |
| 10/30/2003 | CA2481724A1 Screening and therapeutic methods for treating circadian rhythm disorders |
| 10/30/2003 | CA2481548A1 Cytotoxicity assay |
| 10/30/2003 | CA2481512A1 Peptide inhibitors of protein kinase c.gamma. for pain management |
| 10/30/2003 | CA2481411A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 10/30/2003 | CA2481171A1 Hepatitis c virus assay systems |
| 10/30/2003 | CA2480437A1 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 10/30/2003 | CA2480404A1 Fc receptor homolog, reagents, and uses thereof |
| 10/30/2003 | CA2479501A1 Methods for screening for a compound useful in the treatment or prevention of lymphocytic disorders, for inhibiting lymphocyte activity and preventing or treating lymphocytic disorders |
| 10/30/2003 | CA2461562A1 Methods for the electrochemical detection of multiple target compounds |
| 10/29/2003 | EP1357383A1 High-density lipoprotein assay device and method |
| 10/29/2003 | EP1357382A1 Method and system for determining a property of a pavement by measuring natural gamma radiation |
| 10/29/2003 | EP1357379A2 Sodium chloride solution humidified sensor |
| 10/29/2003 | EP1357378A2 Capillary array and electrophoresis apparatus, and related methods |
| 10/29/2003 | EP1357376A1 Skin permeable gas collector and skin permeable gas measuring apparatus |
| 10/29/2003 | EP1357350A1 Oblong alignment and ( electrical ) measurement of width ( medicinal tablet ) with testing chucks and double eccentric |
| 10/29/2003 | EP1357194A2 Adapter for the connection of a biosensor to a measuring device |
| 10/29/2003 | EP1357185A1 4-[(3-methyl-2(3H)-benzothiazolyliden)methylene]-quinoline and -pyridine derivatives as reporter groups in probes for analysis of nucleic acids |
| 10/29/2003 | EP1357181A1 Novel atopic dermatitis-associated gene and proteins |
| 10/29/2003 | EP1357179A1 Solid culture medium and method for preparing the same |
| 10/29/2003 | EP1357132A2 Detection of the her2 receptor by means of biotinylated humanized antibody |
| 10/29/2003 | EP1356860A2 Quality control method of DNA microarray |
| 10/29/2003 | EP1356859A1 Method and apparatus for preparing a fluid |
| 10/29/2003 | EP1356824A2 88KDA tumorigenic growth factor and antagonists |
| 10/29/2003 | EP1356420A1 Devices and methods to image objects |
| 10/29/2003 | EP1356411A2 Molecular docking methods for assessing complementarity of combinatorial libraries to biotargets |
| 10/29/2003 | EP1356410A2 Method and apparatus for predicting a signal peptide cleavage site |
| 10/29/2003 | EP1356304A2 Apparatus and methods for preparing samples |
| 10/29/2003 | EP1356302A2 Method and device for collecting and stabilizing a biological sample |
| 10/29/2003 | EP1356301A2 Occult blood test enhancer |
| 10/29/2003 | EP1356300A2 Oomycete ftsz-mt as a target for antimicrobial-specific biocides |
| 10/29/2003 | EP1356299A2 Method for the diagnosos of alzheimer's disease |
| 10/29/2003 | EP1356298A2 Diagnosis and treatment of disease |
| 10/29/2003 | EP1356297A2 Methods and kits for sequencing polypeptides |
| 10/29/2003 | EP1356296A2 Rapid and sensitive detection of protein aggregation |
| 10/29/2003 | EP1356295A2 Gastric inhibitory polypeptide diagnostic test for detecting susceptibility to type-2 diabetes, impaired glucose tolerance, or impaired fasting glucos |
| 10/29/2003 | EP1356294A2 Laminin alpha 4 subunit as a diagnostic indicator of malignant tumors |
| 10/29/2003 | EP1356293A2 Compositions and methods involving staphylococcus aureus protein staau-r9 |
| 10/29/2003 | EP1356292A2 Marker for antidepressant therapy and methods related thereto |
| 10/29/2003 | EP1356291A2 Bioanalytical reagent, method for production thereof, sensor platforms and detection methods based on use of said bioanalytical reagent |
| 10/29/2003 | EP1356290A2 Method of disrupting interactions between biotin and biotin-binding compounds |
| 10/29/2003 | EP1356289A2 A system for developing assays for personalized medicine |
| 10/29/2003 | EP1356288A1 Screening assay for cotranslational translocation interfering compounds |
| 10/29/2003 | EP1356287A2 Replication assay for detecting anti-viral substances |
| 10/29/2003 | EP1356286A2 Method for estimating metabolic function of xenobiotic and induction thereof |
| 10/29/2003 | EP1356285A2 Differentially expressed epitopes and uses thereof |
| 10/29/2003 | EP1356284A2 Schizophrenia related genes |
| 10/29/2003 | EP1356283A2 Proteins, genes and their use for diagnosis and treatment of cardiac response |
| 10/29/2003 | EP1356282A1 Test strip for simultaneous detection of a plurality of analytes |
| 10/29/2003 | EP1356281A1 Rapid and quantitative proteome analysis and related methods |
| 10/29/2003 | EP1356280A2 Tissue-based water quality biosensors for detecting chemical warfare agents |
| 10/29/2003 | EP1356279A2 Water-soluble, fluorescent, & electrophoretically mobile peptidic substrates for enzymatic reactions and methods for their use in high-throughput screening assays |
| 10/29/2003 | EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 10/29/2003 | EP1356276A2 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action |
| 10/29/2003 | EP1356274A2 Method and apparatus for measurement of the sulfate concentration in air samples |
| 10/29/2003 | EP1356269A2 Thick film conductor composition for use in biosensors |
| 10/29/2003 | EP1356268A2 Mass spectrometric analysis of complex mixtures of immune system modulators |
| 10/29/2003 | EP1356264A2 Apparatus for non-destructively testing material |
| 10/29/2003 | EP1356189A1 Method to evaluate the hydrocarbon potential of sedimentary basins from fluid inclusions |
| 10/29/2003 | EP1356124A2 Circulating epstein-barr virus dna in the serum of patients with gastric carcinoma |
| 10/29/2003 | EP1356121A2 Improved methods for protein identification, characterization and sequencing by tandem mass spectrometry |